Biology Reference
In-Depth Information
98. Wang GP, Levine BL, Binder GK, Berry CC, Malani N, McGarrity G, Tebas P, June CH,
Bushman FD (2009) Analysis of lentiviral vector integration in HIV + study subjects receiv-
ing autologous infusions of gene modified CD4+ T cells. Mol Ther 17:844-850
99. Ter Brake O, Berkhout B (2005) A novel approach for inhibition of HIV-1 by RNA interfer-
ence: counteracting viral escape with a second generation of siRNAs. J RNAi Gene Silencing
1:56-65
100. Schopman NC, Ter Brake O, Berkhout B (2010) Anticipating and blocking HIV-1 escape by
second generation antiviral shRNAs. Retrovirology 7:52
101. Schopman NC, Braun A, Berkhout B (2012) Directed HIV-1 evolution of protease inhibitor
resistance by second-generation short hairpin RNAs. Antimicrob Agents Chemother
56:479-486
102. Berkhout B, Sanders RW (2011) Molecular strategies to design an escape-proof antiviral
therapy. Antiviral Res 92:7-14
103. Ter Brake O, Berkhout B (2008) Development of an RNAi-based gene therapy against HIV-1.
In: Kurreck J (ed) Therapeutic oligonucleotides. RSC Publishing, Cambridge, pp 296-311
104. Liu YP, Haasnoot J, Berkhout B (2007) Design of extended short hairpin RNAs for HIV-1
inhibition. Nucleic Acids Res 35:5683-5693
105. Liu YP, von Eije KJ, Schopman NC, Westerink JT, Ter Brake O, Haasnoot J, Berkhout B
(2009) Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol Ther
17:1712-1723
106. Saayman S, Barichievy S, Capovilla A, Morris KV, Arbuthnot P, Weinberg MS (2008) The
efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-
expressed long hairpin RNA. PLoS One 3:e2602
107. Barichievy S, Saayman S, von Eije KJ, Morris KV, Arbuthnot P, Weinberg MS (2007) The
inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated
regions of the HIV-1 5' long terminal repeat. Oligonucleotides 17:419-431
108. Sano M, Li H, Nakanishi M, Rossi JJ (2008) Expression of long anti-HIV-1 hairpin RNAs for
the generation of multiple siRNAs: advantages and limitations. Mol Ther 16:170-177
109. Konstantinova P, de Vries W, Haasnoot J, Ter Brake O, de Haan P, Berkhout B (2006)
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin
RNA. Gene Ther 13:1403-1413
110. Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova P (2008) Inhibition of HIV-1
by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res
36:2811-2824
111. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay
MA (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA
pathways. Nature 441:537-541
112. McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL,
Burstein H, Peluso RW, Polisky B et al (2008) Artificial miRNAs mitigate shRNA-mediated
toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad
Sci USA 105:5868-5873
113. Castanotto D, Sakurai K, Lingeman R, Li H, Shively L, Aagaard L, Soifer H, Gatignol A,
Riggs A, Rossi JJ (2007) Combinatorial delivery of small interfering RNAs reduces RNAi
efficacy by selective incorporation into RISC. Nucleic Acids Res 35:5154-5164
114. Vickers TA, Lima WF, Nichols JG, Crooke ST (2007) Reduced levels of Ago2 expression
result in increased siRNA competition in mammalian cells. Nucleic Acids Res
35:6598-6610
115. Snyder LL, Esser JM, Pachuk CJ, Steel LF (2008) Vector design for liver-specific expression
of multiple interfering RNAs that target hepatitis B virus transcripts. Antiviral Res
80:36-44
116. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes: lentivirus vector-
mediated drug-inducible RNA interference. J Virol 77:8957-8961
117. Zhou X, Symons J, Hoppes R, Krueger C, Berens C, Hillen W, Berkhout B, Das AT (2007) Improved
single-chain transactivators of the Tet-On gene expression system. BMC Biotechnol 7:6
Search WWH ::
Custom Search